Interleukin-4 Reversibly Inhibits Osteoclastogenesis via Inhibition of NF-κB and Mitogen-activated Protein Kinase Signaling

Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation.

Lacey, D. L., Timms, E., Tan, H.-L., Kelley, M. J., Dunstan, C. R., Burgess, T., Elliott, R., Colombero, A., Elliott, G., Scully, S., et al. (1998) · Cell · doi:10.1016/s0092-8674(00)81569-x · Cited by 5,439

Osteoprotegerin: a novel secreted protein involved in the regulation of bone density.

Simonet, W. S., Lacey, D. L., Dunstan, C. R., Kelley, M., Chang, M.-S., Lüthy, R., Nguyen, H. Q., Wooden, S., Bennett, L., Boone, T., et al. (1997) · Cell · doi:10.1016/s0092-8674(00)80209-3 · Cited by 5,130

Phosphorylation meets ubiquitination: the control of NF-κB activity

Karin, M., & Ben-Neriah, Y. (2000) · Annual Review of Immunology · doi:10.1146/annurev.immunol.18.1.621 · Cited by 4,766

Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL

Yasuda, H., Shima, N., Nakagawa, N., Yamaguchi, K., Kinosaki, M., Mochizuki, S.-I., Tomoyasu, A., Yano, K., Goto, M., Murakami, A., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.7.3597 · Cited by 4,224

Bone Resorption by Osteoclasts

Teitelbaum, S. L. (2000) · Science · doi:10.1126/science.289.5484.1504 · Cited by 3,962

A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function.

Anderson, D. M., Maraskovsky, E., Billingsley, W. L., Dougall, W. C., Tometsko, M. E., Roux, E. R., Teepe, M. C., DuBose, R. F., Cosman, D., & Galibert, L. (1997) · Nature · doi:10.1038/36593 · Cited by 2,290

The IL-4 receptor: signaling mechanisms and biologic functions

Nelms, K., Keegan, A. D., Zamorano, J., Ryan, J. J., & Paul, W. E. (1999) · Annual Review of Immunology · doi:10.1146/annurev.immunol.17.1.701 · Cited by 1,545

TNF-α induces osteoclastogenesis by direct stimulation of macrophages exposed to permissive levels of RANK ligand

Lam, J., Takeshita, S., Barker, J. E., Kanagawa, O., Ross, F. P., & Teitelbaum, S. L. (2000) · Journal of Clinical Investigation · doi:10.1172/jci11176 · Cited by 1,440

Tumor Necrosis Factor α Stimulates Osteoclast Differentiation by a Mechanism Independent of the Odf/Rankl–Rank Interaction

Kobayashi, K., Takahashi, N., Jimi, E., Udagawa, N., Takami, M., Kotake, S., Nakagawa, N., Kinosaki, M., Yamaguchi, K., Shima, N., et al. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.191.2.275 · Cited by 1,309

TRAF6 is a signal transducer for interleukin-1

Cao, Z., Xiong, J., Takeuchi, M., Kurama, T., & Goeddel, D. V. (1996) · Nature · doi:10.1038/383443a0 · Cited by 1,305

Identification of Estrogen-Regulated Genes of Potential Importance for the Regulation of Trabecular Bone Mineral Density

Lindberg, M. K., Movérare, S., Eriksson, A.-L., Skrtic, S., Gao, H., Dahlman‐Wright, K., Gustafsson, J.-Α., & Ohlsson, C. (2002) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2002.17.12.2183 · Cited by 41

Mixed Periodontal Th1-Th2 Cytokine Profile in Actinobacillus actinomycetemcomitans -Specific Osteoprotegerin Ligand (or RANK-L)- Mediated Alveolar Bone Destruction In Vivo

Teng, Y.-T. A. (2002) · Infection and Immunity · doi:10.1128/iai.70.9.5269-5273.2002 · Cited by 40

Harnessing the power of macrophages/monocytes for enhanced bone tissue engineering

Dong, L., & Wang, C. (2013) · Trends in biotechnology · doi:10.1016/j.tibtech.2013.04.001 · Cited by 39

Bone Malformations in Interleukin-18 Transgenic Mice

Kawase, Y., Hoshino, T., Yokota, K., Kuzuhara, A., Nakamura, M., Maeda, Y., Nishiwaki, E., Zenmyo, M., Hiraoka, K., Aizawa, H., et al. (2003) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2003.18.6.975 · Cited by 39

Involvement of Upstream Stimulatory Factors 1 and 2 in RANKL-induced Transcription of Tartrate-resistant Acid Phosphatase Gene during Osteoclast Differentiation

Liu, Y. F., Shi, Z., Silveira, A. C., Liu, J., Sawadogo, M., Yang, H., & Feng, X. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m212093200 · Cited by 39

Osteoimmunology: A View from the Bone

David, J. (2007) · Advances in immunology · doi:10.1016/s0065-2776(07)95005-1 · Cited by 38

Inhibition of apoptosis signal-regulating kinase 1 enhances endochondral bone formation by increasing chondrocyte survival

Eaton, G. J., Zhang, Q.-S., Diallo, C., Matsuzawa, A., Ichijo, H., Steinbeck, M. J., & Freeman, T. A. (2014) · Cell Death and Disease · doi:10.1038/cddis.2014.480 · Cited by 37

IL-37 inhibits lipopolysaccharide-induced osteoclast formation and bone resorption in vivo

Saeed, J., Kitaura, H., Kimura, K., Ishida, M., Sugisawa, H., Ochi, Y., Kishikawa, A., & Takano‐Yamamoto, T. (2016) · Immunology Letters · doi:10.1016/j.imlet.2016.04.004 · Cited by 36

Cell-Autonomous CCL5 Transcription by Memory CD8 T Cells Is Regulated by IL-4

Marçais, A., Coupet, C., Walzer, T., Tomkowiak, M., Ghittoni, R., & Marvel, J. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.7.4451 · Cited by 33

Thonzonium bromide inhibits RANKL-induced osteoclast formation and bone resorption in vitro and prevents LPS-induced bone loss in vivo

Zhu, X. Y., Gao, J., Landao‐Bassonga, E., Pavlos, N. J., Qin, A., Steer, J. H., Zheng, M., Dong, Y., & Cheng, T. S. (2016) · Biochemical Pharmacology · doi:10.1016/j.bcp.2016.02.013 · Cited by 33

Ellagic acid protects ovariectomy‐induced bone loss in mice by inhibiting osteoclast differentiation and bone resorption

Lin, X., Yuan, G., Li, Z., Zhou, M., Hu, X., Song, F., Shao, S., Fu, F., Zhao, J., Xu, J., et al. (2020) · Journal of Cellular Physiology · doi:10.1002/jcp.29520 · Cited by 33

Current perspectives of osteoclastogenesis through estrogen modulated immune cell cytokines

Uehara, I. A., Soldi, L. R., & Silva, M. J. B. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.117921 · Cited by 34

Cytokines and Bone: Osteoimmunology

Lorenzo, J. (2020) · Handbook of experimental pharmacology · doi:10.1007/164_2019_346 · Cited by 32

Serum Calcium-decreasing Factor, Caldecrin, Inhibits Osteoclast Differentiation by Suppression of NFATc1 Activity

Hasegawa, H., Kido, S., Tomomura, M., Fujimoto, K., Ohi, M., Kiyomura, M., Kanegae, H., Inaba, A., Sakagami, H., & Tomomura, A. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.068742 · Cited by 32

Exercise and osteoimmunology in bone remodeling

Zhao, Z., Du, Y., Yan, K., Zhang, L., & Guo, Q. (2024) · The FASEB Journal · doi:10.1096/fj.202301508rrr · Cited by 34

Pathophysiology of interleukin-1 receptor-associated kinase-M: implications in refractory state

López‐Collazo, E., Fuentes‐Prior, P., Arnalich, F., & del Fresno, C. (2006) · Current Opinion in Infectious Diseases · doi:10.1097/01.qco.0000224817.35105.7d · Cited by 31

Cell Adhesion Molecule CD166 Drives Malignant Progression and Osteolytic Disease in Multiple Myeloma

Xu, L., Mohammad, K. S., Wu, H., Crean, C., Poteat, B. A., Cheng, Y., Cardoso, A. A., Machal, C., Hanenberg, H., Abonour, R., et al. (2016) · Cancer Research · doi:10.1158/0008-5472.can-16-0517 · Cited by 31

Association of interleukin 4 (-590 T/C) and interleukin 4 receptor (Q551R A/G) gene polymorphisms with acne vulgaris

Robaee, A. A. A., Alzolibani, A. A., Shobaili, H. A. A., & Settin, A. (2012) · Annals of Saudi Medicine · doi:10.5144/0256-4947.2012.349 · Cited by 28

Interleukin-4 directly inhibits tumor necrosis factor-alpha-mediated osteoclast formation in mouse bone marrow macrophages.

Kitaura, H., Nagata, N., Fujimura, Y., Hotokezaka, H., Tatamiya, M., Nakao, N., Yoshida, N., & Nakayama, K. (2003) · Immunology Letters · doi:10.1016/s0165-2478(03)00082-8 · Cited by 33

Complex Regulation of Tartrate-resistant Acid Phosphatase (TRAP) Expression by Interleukin 4 (IL-4)

Yu, M., Moreno, J. L., Stains, J. P., & Keegan, A. D. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.001016 · Cited by 29

PD98059 enhances C2 myoblast differentiation through p38 MAPK activation: a novel role for PD98059

Al‐Shanti, N., & Stewart, C. E. (2008) · Journal of Endocrinology · doi:10.1677/joe-08-0151 · Cited by 28

Transplanted interleukin-4--secreting mesenchymal stromal cells show extended survival and increased bone mineral density in the murine femur

Lin, T., Pajarinen, J., Kohno, Y., Maruyama, M., Romero-López, M., Huang, J., Nathan, K., Khan, T. N., Yao, Z., & Goodman, S. B. (2018) · Cytotherapy · doi:10.1016/j.jcyt.2018.06.009 · Cited by 27

T cells are able to promote lipopolysaccharide‐induced bone resorption in mice in the absence of B cells

Yamaguchi, M., Ukai, T., Kaneko, T., Yoshinaga, M., Yokoyama, M., Ozaki, Y., & Hara, Y. (2008) · Journal of Periodontal Research · doi:10.1111/j.1600-0765.2008.01083.x · Cited by 26

Ginsenoside Re Inhibits Osteoclast Differentiation in Mouse Bone Marrow-Derived Macrophages and Zebrafish Scale Model

Park, C., Kim, H.-M., Kim, D. H., Han, H.-J., Noh, H., Jang, J., Park, S.-H., Chae, H., Chae, S., Ryu, E. K., et al. (2016) · Molecules and Cells · doi:10.14348/molcells.2016.0111 · Cited by 25

Interleukin‐4 repairs wear particle induced osteolysis by modulating macrophage polarization and bone turnover

Pajarinen, J., Lin, T., Nabeshima, A., Sato, T., Gibon, E., Jämsen, E., Khan, T. N., Yao, Z., & Goodman, S. B. (2020) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.37142 · Cited by 27

Interleukin-10-Producing B Cells Help Suppress Ovariectomy-Mediated Osteoporosis

Wang, Y., Zhang, W., Lim, S.-M., Xu, L., & Jin, J. (2020) · Immune Network · doi:10.4110/in.2020.20.e50 · Cited by 24

Osteostat/Tumor Necrosis Factor Superfamily 18 Inhibits Osteoclastogenesis and Is Selectively Expressed by Vascular Endothelial Cells

Nardelli, B., Zaritskaya, L., McAuliffe, W. J., Ni, Y., Lincoln, C., Cho, Y. H., Birse, C. E., Halpern, W., Ullrich, S. J., & Moore, P. A. (2005) · Endocrinology · doi:10.1210/en.2005-0518 · Cited by 24

Bisphosphonates

Iannitti, T., Rosini, S., Lodi, D., Frediani, B., Rottigni, V., & Palmieri, B. (2012) · American Journal of Therapeutics · doi:10.1097/mjt.0b013e318247148f · Cited by 21

Direct and indirect effects of estrogen on osteoclasts.

Oursler, M. J. (2003) · PubMed · Cited by 21

New perspectives on traumatic bone infections

Tang, R., Yang, J., & Fei, J. (2020) · Chinese Journal of Traumatology · doi:10.1016/j.cjtee.2020.05.009 · Cited by 21

A Rapid Multiparameter Approach to Study Factors that Regulate Osteoclastogenesis: Demonstration of the Combinatorial Dominant Effects of TNF-α and TGF-ß in RANKL-Mediated Osteoclastogenesis

Huang, W., Drissi, M., O'Keefe, R. J., & Schwarz, E. M. (2003) · Calcified Tissue International · doi:10.1007/s00223-003-0059-8 · Cited by 21

p38 MAPK as a Potential Therapeutic Target for Inflammatory Osteolysis

Shi, W., & Siegal, G. P. (2006) · Advances in Anatomic Pathology · doi:10.1097/pap.0b013e31802ef4f2 · Cited by 19

IL1β and TNFα promote RANKL-dependent adseverin expression and osteoclastogenesis

Wang, Y., Galli, M., Silver, A. S., Lee, W., Song, Y., Mei, Y., Bachus, C., Glogauer, M., & McCulloch, C. A. (2018) · Journal of Cell Science · doi:10.1242/jcs.213967 · Cited by 21

Reduced cortical bone mass in mice with inactivation of interleukin‐4 and interleukin‐13

Silfverswärd, C., Larsson, S., Ohlsson, C., Frost, A., & Nilsson, O. (2007) · Journal of Orthopaedic Research® · doi:10.1002/jor.20361 · Cited by 19

Interleukin‐4 and interleukin‐13 potentiate interleukin‐1 induced secretion of interleukin‐6 in human osteoblast‐like cells

Silfverswärd, C., Frost, A., Brändström, H., Nilsson, O., & Ljunggren, Ö. (2004) · Journal of Orthopaedic Research® · doi:10.1016/j.orthres.2004.02.008 · Cited by 19

Peroxidase enzymes inhibit osteoclast differentiation and bone resorption

Panagopoulos, V., Liapis, V., Zinonos, I., Hay, S., Leach, D. A., Ingman, W., DeNichilo, M. O., Atkins, G. J., Findlay, D. M., Zannettino, A. C. W., et al. (2017) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2016.11.007 · Cited by 18

The Effects of Immune Cell Products (Cytokines and Hematopoietic Cell Growth Factors) on Bone Cells

Lorenzo, J. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-800571-2.00009-8 · Cited by 20

Reciprocal effects of Interferon‐γ and IL ‐4 on differentiation to osteoclast‐like cells by RANKL or LPS

Hu, Y., Ek‐Rylander, B., Wendel, M., & Andersson, G. N. (2013) · Oral Diseases · doi:10.1111/odi.12189 · Cited by 18

Obatoclax Regulates the Proliferation and Fusion of Osteoclast Precursors through the Inhibition of ERK Activation by RANKL

Oh, J., Lee, J. Y., Park, J. H., No, J. H., & Lee, N. K. (2015) · Molecules and Cells · doi:10.14348/molcells.2015.2340 · Cited by 17

Interleukin 19 suppresses RANKL-induced osteoclastogenesis via the inhibition of NF-κB and p38MAPK activation and c-Fos expression in RAW264.7 cells

Tsubaki, M., Takeda, T., Matsuda, T., Yamamoto, Y., Higashinaka, A., Yamamoto, K., Tsurushima, K., Ishizaka, T., & Nishida, S. (2021) · Cytokine · doi:10.1016/j.cyto.2021.155591 · Cited by 17

Hdac3 deletion in myeloid progenitor cells enhances bone healing in females and limits osteoclast fusion via Pmepa1

Molstad, D. H. H., Zars, E., Norton, A., Mansky, K., Westendorf, J., & Bradley, E. W. (2020) · Scientific Reports · doi:10.1038/s41598-020-78364-5 · Cited by 16

Photothermal-Controlled Release of IL-4 in IL-4/PDA-Immobilized Black Titanium Dioxide (TiO2) Nanotubes Surface to Enhance Osseointegration: An In Vivo Study

Chen, B., Liang, Y., Song, Y., Liang, Y., Jiao, J., Bai, H., & Li, Y. (2022) · Materials · doi:10.3390/ma15175962 · Cited by 13

Osteoprotective effect by interleukin-4 (IL-4) on lipoprotein-induced periodontitis

Teixeira, J. F. L., Henning, P., Magalhães, F. A. C., Coletto-Nunes, G., Marcelino, T. F., Westerlund, A., Movérare‐Skrtic, S., de Oliveira, G. J. P. L., Lerner, U. H., & de Souza, P. C. (2023) · Cytokine · doi:10.1016/j.cyto.2023.156399 · Cited by 13

Inflammatory Arthritis and Bone Metabolism Regulated by Type 2 Innate and Adaptive Immunity

Omata, Y., Frech, M., Saito, T., Schett, G. A., Zaiss, M. M., & Tanaka, S. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23031104 · Cited by 12

Osteoclast Apoptosis in Rheumatic Diseases Characterized by a High Level of Bone Resorption (Osteoporosis, Rheumatoid Arthritis, Myeloma and Pagets Disease of Bone)

Roux, S., & Brown, J. P. (2009) · Current Rheumatology Reviews · doi:10.2174/157339709788298428 · Cited by 12

Role of Muramyl Dipeptide in Lipopolysaccharide-Mediated Biological Activity and Osteoclast Activity

Kitaura, H., Ishida, M., Kimura, K., Sugisawa, H., Kishikawa, A., Shima, K., Ogawa, S., Qi, J., & Shen, W.-R. (2018) · Analytical Cellular Pathology · doi:10.1155/2018/8047610 · Cited by 14

Biomaterial-based osteoimmunomodulatory strategies via the TLR4-NF-κB signaling pathway: A review

Xing, H., Li, R., Qing, Y., Ying, B., & Qin, Y. (2021) · Applied Materials Today · doi:10.1016/j.apmt.2021.100969 · Cited by 13

Protective effects of IL-4 on Bacillus Calmette-Guerin and lipopolysaccharide induced immunological liver injury in mice

Zhang, N. N., Huang, N. Y., Zhou, X. K., Luo, X. L., Liu, C. Y., Zhang, Y., Qiu, J., Zhang, Y. B., Teng, X., Luo, C., et al. (2011) · Inflammation Research · doi:10.1007/s00011-011-0383-9 · Cited by 11

The Role of Jak/STAT Pathways in Osteoclast Differentiation

Lee, Y., & Kim, H. H. (2011) · Biomolecules & Therapeutics · doi:10.4062/biomolther.2011.19.2.141 · Cited by 10

IL-4 absence triggers distinct pathways in apical periodontitis development

Freire, M. S., Oliveira-Júnior, N. G., Lima, S. M. D. F., Porto, W. F., Martins, D. C. M., Silva, O. N., Chaves, S. B., de Sousa, M. V., Ricart, C. A. O., Castro, M. S., et al. (2020) · Journal of Proteomics · doi:10.1016/j.jprot.2020.104080 · Cited by 10

Development of a chimaeric receptor approach to study signalling by tumour necrosis factor receptor family members.

Xu, D., Shi, Z.-Q., Mcdonald, J., Pan, G., Cao, X.-M., Yu, X.-Q., & Feng, X. (2004) · Biochemical Journal · doi:10.1042/bj20040961 · Cited by 12

Bone Tissue Engineering: Growth Factors and Cytokines

Hollinger, J. O., Srinivasan, A., Alvarez, P., Hsu, E., McBride, S., Eppell, S. J., Baskin, J. Z., Waters, H., & Gruber, R. (2011) · Comprehensive Biomaterials · doi:10.1016/b978-0-08-055294-1.00160-4 · Cited by 10

Local Controlled Delivery of IL-4 Decreases Inflammatory Bone Loss in a Murine Model of Periodontal Disease

Shehabeldin, M., Kobyra, J. A., Cho, Y., Gao, J., Chong, R., Tabib, T., Lafyatis, R., Little, S. R., & Sfeir, C. S. (2024) · The Journal of Immunology · doi:10.4049/jimmunol.2400332 · Cited by 9

Diversity of multinucleated giant cells by microstructures of hydroxyapatite and plasma components in extraskeletal implantation model

Morishita, K., Tatsukawa, E., Shibata, Y., Suehiro, F., Kamitakahara, M., Yokoi, T., Ioku, K., Umeda, M., Nishimura, M., & Ikeda, T. (2016) · Acta Biomaterialia · doi:10.1016/j.actbio.2016.05.002 · Cited by 9

Regulation of Osteoclast Activity

Baron, R., & Horne, W. C. (2005) · Springer eBooks · doi:10.1007/1-84628-016-8_3 · Cited by 9

Suramin interacts with RANK and inhibits RANKL-induced osteoclast differentiation

Regmi, A., Fuson, T. R., Yang, X., Kays, J. S., Moxham, C., Zartler, E. R., Chandrashekhar, S., & Galvin, R. J. S. (2005) · Bone · doi:10.1016/j.bone.2004.09.022 · Cited by 9

Protective effect of p38 MAPK inhibitor on wear debris-induced inflammatory osteolysis through downregulating RANK/RANKL in a mouse model

Chen, D., Li, Y., Guo, F., Lü, Z., Hei, C., Li, P., & Jin, Q. (2015) · Genetics and Molecular Research · doi:10.4238/2015.january.15.6 · Cited by 8

Local regulators of bone

Sims, N. A., & Lorenzo, J. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-814841-9.00050-6 · Cited by 7

Targeted functional analysis of p300 coactivator in Wnt/β-catenin signaling pathway using phosphoproteomic and biochemical approaches

Ma, H., Guo, M., Shan, B., & Xia, Z. (2012) · Journal of Proteomics · doi:10.1016/j.jprot.2012.03.009 · Cited by 8

Mechanisms of bone resorption and new bone formation in spondyloarthropathies

Huang, W., & Schwarz, E. (2002) · Current Rheumatology Reports · doi:10.1007/s11926-002-0059-0 · Cited by 9

Role of cytokines and chemokines in cartilage and bone destruction in arthritis

Goldring, M. B., & Goldring, S. R. (2002) · Current Opinion in Orthopedics · doi:10.1097/00001433-200210000-00005 · Cited by 8

Dynamic analysis of STAT6 signalling in living cells

Nelson, G., Wilde, G. J. C., Spiller, D. G., Sullivan, E., Unitt, J. F., & White, M. (2002) · FEBS Letters · doi:10.1016/s0014-5793(02)03672-4 · Cited by 8

Outlining cell interaction and inflammatory cytokines on UV-photofunctionalized mixed-phase TiO2 thin film

Pantaroto, H. N., de Almeida, A. B., Gomes, O. P., Matos, A. O., Landers, R., Casarin, R. C. V., da Silva, J. H. D., Nociti, F. H., & Barão, V. A. R. (2020) · Materials Science and Engineering C · doi:10.1016/j.msec.2020.111438 · Cited by 6

Emerging Roles of Eosinophils in Bone

Andreev, D., & Porschitz, P. (2025) · Current Osteoporosis Reports · doi:10.1007/s11914-025-00913-6 · Cited by 5

Extracellular Signal-Regulated Kinases Play Essential but Contrasting Roles in Osteoclast Differentiation

Kim, C. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242015342 · Cited by 7

The Effect of Methyl‐β‐cyclodextrin on the Differentiation of RAW264 Cells into Osteoclasts

Ogawa, Y., Goda, S., & Morita, S. (2007) · Oral Science International · doi:10.1016/s1348-8643(08)80002-x · Cited by 5

6.2 Bone Tissue Engineering: Growth Factors and Cytokines ☆

Hollinger, J. O., Alvarez, P., Ducheyne, P., Srinivasan, A., Baskin, J. Z., Waters, H., & Gruber, R. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-803581-8.10205-x · Cited by 5

Systemic and Local Regulators of Bone Remodeling

Hurley, M. M., & Lorenzo, J. (2004) · Springer eBooks · doi:10.1007/978-1-4471-3777-1_3 · Cited by 4

The Effects of Immune Cell Products (Cytokines and Hematopoietic Cell Growth Factors) on Bone Cells

Lorenzo, J. (2010) · Elsevier eBooks · doi:10.1016/b978-0-12-375670-1.10007-x · Cited by 4

Nouvelles cibles thérapeutiques dans l’ostéoporose

Roux, S. (2010) · Revue du Rhumatisme · doi:10.1016/j.rhum.2009.10.032 · Cited by 3

ThPOK Inhibits Osteoclast Formation Via NFATc1 Transcription and Function

Zou, W., Izawa, T., Rohatgi, N., Zou, S. Y., Li, Y., & Teitelbaum, S. L. (2022) · JBMR Plus · doi:10.1002/jbm4.10613 · Cited by 3

Expression of Osteoclastogenesis-related Genes in Rheumatoid Arthritis Synovial Macrophages

Ji, J. D., Kim, T., Lee, B., Choi, S. J., Lee, Y. H., & Song, G. G. (2011) · Journal of Rheumatic Diseases · doi:10.4078/jrd.2011.18.1.11 · Cited by 3

Cytokines and the Pathogenesis of Osteoporosis

Lorenzo, J. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-415853-5.00038-8 · Cited by 3

Kinins : important regulators in inflammation induced bone resorption

Brechter, A. B. (2006) · Cited by 3

Role of Interleukins on Physiological and Pathological Bone Resorption and Bone Formation: Effects by Cytokines in The IL-1 and IL-2 Families

Lerner, U. H. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.11202-4 · Cited by 3

Immunoregulatory cytokines in mouse placental extracts inhibit in vitro osteoclast differentiation of murine macrophages

Canellada, A. M., Custidiano, A., Abraham, F., Rey, E., & Gentile, T. (2013) · Placenta · doi:10.1016/j.placenta.2012.12.015 · Cited by 2

Mechanistic Role of RANKL in Cancer-induced Bone Diseases and Development of a Targeted Therapy to Inhibit this Pathway

Dougall, W. C. (2010) · Elsevier eBooks · doi:10.1016/b978-0-12-374895-9.00032-3 · Cited by 2

Interleukin-4 −590 T>C and interleukin-4 receptor Q551R A>G gene polymorphisms in Saudi cases with alopecia areata

Alzolibani, A. A., Robaee, A. A. A., Shobaili, H. A. A., Saif, G. A. B., Alsaif, F., Ali, A., & Settin, A. (2015) · Journal of the Egyptian Public Health Association · doi:10.1097/01.epx.0000461326.05328.d3 · Cited by 2

Osteoarthritis and the Immune System

Goldring, M. B., Dayer, J., & Goldring, S. R. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-800571-2.00014-1 · Cited by 2

Immunobiology and Bone

Pacifici, R., & Weitzmann, M. N. (2018) · Wiley eBooks · doi:10.1002/9781119266594.ch128 · Cited by 2

IL‐4 promotes chondrogenesis of bone marrow mesenchymal stem cells and blockade of IL‐4Rα retards the endochondral ossification during rat embryonic bone development

Hao, Y., Meng, Q., Chang, L., Qiu, M., Han, J., Wang, Z., Li, C., Ma, J., & Zhang, X. (2024) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/bcpt.14088 · Cited by 1

Role of Calpain in Immunobiology of Neurodegenerative Diseases

Trager, N., Haque, A., Ray, S. K., Das, A., & Banik, N. L. (2013) · Springer eBooks · doi:10.1007/978-1-4614-9099-9_1 · Cited by 1

Cytokines and the pathogenesis of osteoporosis

Lorenzo, J. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-813073-5.00033-2 · Cited by 1

Origin and Differentiation of Osteoclasts

Sanjay, A., & Charles, J. F. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.11161-4 · Cited by 1

Osteotropic cytokines : expression in human gingival fibroblasts and effects on bone

Palmqvist, P. (2006) · KTH Publication Database DiVA (KTH Royal Institute of Technology)

Cytokine regulation of bone destruction

Lubberts, E., & van den Berg, W. B. (2004) · Birkhäuser Basel eBooks · doi:10.1007/978-3-0348-7883-8_11

Osteopenia and osteoporosis in HIV-infected patients

Gołaszewska, D., & Racewicz, A. J. (2007) · HIV & AIDS Review · doi:10.1016/s1730-1270(10)60072-0

Arthritis and immune-mediated bone loss - role of estrogen signalling pathways

Engdahl, C. (2012) · Gothenburg University Publications Electronic Archive (Gothenburg University)

Involvements of mitogen-activated protein kinase cascades in osteoclastogenesis

Hirata, K., & Sugita, T. (2011) · Inflammation and Regeneration · doi:10.2492/inflammregen.31.425

3. of Osteoclast Activity

Baron, R., & Horne, W. C. (2005)

The Prevention and Treatment of Inflammation-Induced Bone Loss: Can It Be Done?

Romas, E. (2006) · Elsevier eBooks · doi:10.1016/b978-0-323-03437-1.50033-6

Elucidating Differences in Osteoclast Activation Mechanisms: Looking for Targets to Prevent Pathological Bone Resorption

Trebec‐Reynolds, D. P. (2010) · TSpace (University of Toronto)

Regulation of bone and joint inflammation by type 2 innate lymphoid cells

Omata, Y., Zaiss, M. M., Frech, M., Schett, G. A., & Tanaka, S. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-85831-1.00026-7

Immunomodulation of Bone Remodeling in Osteoporosis

Hazra, S., Chattopadhyay, S., & Goswami, R. (2023) · IntechOpen eBooks · doi:10.5772/intechopen.1003281

In Vitro Assessment of 4-Acetyl-Antroquinonol B and Erinacine A in Suppressing Breast Cancer-Induced Osteoclastogenesis

Huang, Y.-M., Fu, Y.-S., Chen, W., & Lu, H. (2024) · International journal of medicinal mushrooms · doi:10.1615/intjmedmushrooms.2024053977

IL-4 Correlates With Bone Mineral Density in Men, and IL-4 Depletion May Drive Bone Loss in Men With HIV

Ofotokun, I., Titanji, K., Dabeer, S., Tripathi, A. K., Bedi, B., Kirkpatrick, C. M., Nguyen, T. B., & Weitzmann, M. N. (2025) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiaf570

The Roles of the Protein Tyrosine Phosphatases PTPN3 and PTPN4 in T cells and PTPN11 in Tissue Remodeling.

Bauler, T. J. (2009) · Deep Blue (University of Michigan)

Effects of interleukin-4 and interleukin-13 on bone.

Silfverswärd, C. (2008) · Uppsala University Publications (Uppsala University)

Role of the osteoclast in bone regeneration induced by mesenchymal stem cells and calcium phosphate biomaterials

Humbert, P. (2020) · theses.fr (ABES) · doi:10.70675/8e4fd827zbb15z43a0zb23ez3e157122f5fa

Roles of gut metabolites on bone mineralization and remodeling: impact of metabolic dysregulation on the gut-immune-bone axis

Basak, S., Hridayanka, K. S. N., & Duttaroy, A. K. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1774824

Interleukin‐4 inhibits RANKL‐induced NFATc1 expression via STAT6: A novel mechanism mediating its blockade of osteoclastogenesis

Cheng, J. Q., Liu, J., Shi, Z., Xu, D., Luo, S., Siegal, G. P., Feng, X., & Shi, W. (2011) · Journal of Cellular Biochemistry · doi:10.1002/jcb.23269 · Cited by 52

IL-4 abrogates osteoclastogenesis through STAT6-dependent inhibition of NF-κB

Abu‐Amer, Y. (2001) · Journal of Clinical Investigation · doi:10.1172/jci10530 · Cited by 191

IL-4 suppresses osteoclast development and mature osteoclast function by a STAT6-dependent mechanism: irreversible inhibition of the differentiation program activated by RANKL

Moreno, J. L., Kaczmarek, M., Keegan, A. D., & Tondravi, M. M. (2003) · Blood · doi:10.1182/blood-2002-11-3437 · Cited by 151

T-Cells Mediate an Inhibitory Effect of Interleukin-4 on Osteoclastogenesis

Mirosavljevic, D., Quinn, J. M. W., Elliott, J., Horwood, N. J., Martin, T. J., & Gillespie, M. T. (2003) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2003.18.6.984 · Cited by 71

Interleukin-4 inhibits RANKL-induced expression of NFATc1 and c-Fos: A possible mechanism for downregulation of osteoclastogenesis

Kamel Mohamed, S. G., Sugiyama, E., Shinoda, K., Hounoki, H., Taki, H., Maruyama, M., Miyahara, T., & Kobayashi, M. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.02.049 · Cited by 51